Release Date: 12/11/09 18:13 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 23.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%